1 | 1) Inosine 5'-monophosphate | 1件: Inosine Inosine | 1件: D00054
D00054
| - | - | 1件: 17 17 |
2 | 1-(2-Isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d] pyrimidin-4-one | - | - | - | - | 1件: 17 17 |
3 | [18F]FDOPA | - | - | - | - | 2件: 6 6, 17 |
4 | [F-18]PBR06 | - | - | - | - | 2件: 13 13, 17 |
5 | AAV2-GDNF gene therapy | - | - | - | - | 1件: 17 17 |
6 | Abdominal compression | - | - | - | - | 2件: 6 6, 17 |
7 | Accelerometer | - | - | - | - | 1件: 17 17 |
8 | Adjuvant without active component | - | - | - | - | 2件: 6 6, 17 |
9 | AFFITOPE® PD01A + Adjuvant | - | - | - | - | 2件: 6 6, 17 |
10 | AFFITOPE® PD03A + Adjuvant | - | - | - | - | 1件: 17 17 |
11 | Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation | - | - | - | - | 1件: 17 17 |
12 | Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation | - | - | - | - | 1件: 17 17 |
13 | Ampreloxetine | 1件: Ampreloxetine Ampreloxetine | 1件: D11688
D11688
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 17 |
14 | Ampreloxetine chydrochloride | 1件: Ampreloxetine Ampreloxetine | 1件: D11688
D11688
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 17 |
15 | Ampreloxetine hydrochloride | 1件: Ampreloxetine Ampreloxetine | 1件: D11688
D11688
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 17 |
16 | Angiotensin | 1件: Angiotensin II Angiotensin II | 2件: D00150
D00150
,
D02014
| 2件: AGTR1 AGTR1, AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 7件: 17 17, 19, 46, 66, 86, 222, 224 |
17 | Angiotensin-(1-7) | 1件: Angiotensin II Angiotensin II | 2件: D00150
D00150
,
D02014
| 2件: AGTR1 AGTR1, AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 17 17 |
18 | Anti-Parkinson medication | - | - | - | - | 5件: 5 5, 6, 7, 8, 17 |
19 | ATH434 dose level 1 | - | - | - | - | 1件: 17 17 |
20 | ATH434 dose level 2 | - | - | - | - | 1件: 17 17 |
21 | Atomexetine | - | - | - | - | 1件: 17 17 |
22 | Atomoxetine | 1件: Atomoxetine Atomoxetine | 2件: D02574
D02574
,
D07473
| 1件: SLC6A2 SLC6A2 💬 | 1件: Synaptic vesicle cycle Synaptic vesicle cycle 💬 | 4件: 6 6, 8, 13, 17 |
23 | Autologous Adipose Mesenchymal Stem Cell Implantation | - | - | - | - | 1件: 17 17 |
24 | Autologous mesenchymal stem cells | - | - | - | - | 5件: 2 2, 6, 13, 17, 46 |
25 | Automated abdominal binder | - | - | - | - | 1件: 17 17 |
26 | AZD3241 | - | - | - | - | 2件: 6 6, 17 |
27 | AZD3241 100mg | - | - | - | - | 1件: 17 17 |
28 | AZD3241 300mg | - | - | - | - | 1件: 17 17 |
29 | Azilect | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 4件: 2 2, 5, 6, 17 |
30 | AZILECT 1 mg comprimidos | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
31 | Behavioral: BCI-FIT active querying | - | - | - | - | 3件: 2 2, 6, 17 |
32 | Behavioral: BCI-FIT adaptive signal modeling | - | - | - | - | 3件: 2 2, 6, 17 |
33 | Behavioral: BCI-FIT language modeling | - | - | - | - | 3件: 2 2, 6, 17 |
34 | Behavioral: BCI-FIT multi-modal access | - | - | - | - | 3件: 2 2, 6, 17 |
35 | Behavioral: Clinical characteristics of AMS patients | - | - | - | - | 1件: 17 17 |
36 | Behavioral: Conservative Measures for Orthostatic Hypotension | - | - | - | - | 2件: 6 6, 17 |
37 | Behavioral: MOntreal Cognitive Assessment (MoCA) | - | - | - | - | 1件: 17 17 |
38 | BHV-3241 | - | - | - | - | 1件: 17 17 |
39 | BHV-4157 | - | - | - | - | 1件: 17 17 |
40 | BIIB101 | - | - | - | - | 1件: 17 17 |
41 | Blood sampling | - | - | - | - | 6件: 13 13, 17, 19, 46, 51, 96 |
42 | BOTULINUM TOXIN TYPE A | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 10件: 2 2, 5, 6, 7, 13, 15, 17, 70, 113, 149 |
43 | BQ123 | - | - | - | - | 1件: 17 17 |
44 | Brain Magnetic Resonance Imaging (MRI) | - | - | - | - | 1件: 17 17 |
45 | BYDUREON | 1件: Exenatide Exenatide | 1件: D04121
D04121
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 2件: 6 6, 17 |
46 | Captopril | 1件: Captopril Captopril | 1件: D00251
D00251
| 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 2件: 17 17, 86 |
47 | Carbidopa | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 9件: 2 2, 4, 6, 13, 17, 90, 140, 164, 201 |
48 | Carbidopa 200mg oral dose | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
49 | Carbonate | 1件: Carbonate ion Carbonate ion | - | - | - | 12件: 2 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 |
50 | CS10BR05 | - | - | - | - | 1件: 17 17 |
51 | DaTSCAN | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 4件: 2 2, 5, 6, 17 |
52 | DaTSCAN™ Ioflupane (123I) Injection | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 3件: 5 5, 6, 17 |
53 | Deep Brain Stimulation | - | - | - | - | 5件: 5 5, 6, 7, 8, 17 |
54 | Determination of objective and subjective pain threshold | - | - | - | - | 1件: 17 17 |
55 | Diagnostic Test: [18F]-RO6958948 | - | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
56 | Diagnostic Test: Elecsys (Roche) Abeta42, Ttau and Ptau | - | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
57 | Diagnostic Test: Flutemetamol F18 Injection | 2件: Flutemetamol Flutemetamol, Flutemetamol (18F) | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
58 | Diagnostic Test: Lumipulse (Fujirebio) Abeta42, Ttau and Ptau | - | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
59 | Domperidone | 1件: Domperidone Domperidone | 2件: D01745
D01745
,
D07868
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 5件: 6 6, 13, 17, 51, 230 |
60 | DOPS | 1件: Droxidopa Droxidopa | 1件: D01277
D01277
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 6 6, 17 |
61 | Droxidopa | 1件: Droxidopa Droxidopa | 1件: D01277
D01277
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 5 5, 6, 17, 169, 170 |
62 | EGCG | 1件: Epigallocatechin gallate Epigallocatechin gallate | - | - | - | 9件: 6 6, 8, 13, 17, 28, 85, 113, 206, 299 |
63 | EGCG as putative neuroprotective agent | 1件: Epigallocatechin gallate Epigallocatechin gallate | - | - | - | 1件: 17 17 |
64 | Emeramide | 1件: Emeramide Emeramide | - | - | - | 2件: 5 5, 17 |
65 | ENTACAPONE | 1件: Entacapone Entacapone | 1件: D00781
D00781
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
66 | Entacapone 400mg oral dose | 1件: Entacapone Entacapone | 1件: D00781
D00781
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
67 | EXENATIDE | 1件: Exenatide Exenatide | 1件: D04121
D04121
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 6件: 6 6, 17, 72, 78, 193, 233 |
68 | Exenatide Pen Injector [Bydureon] | 1件: Exenatide Exenatide | 1件: D04121
D04121
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 17 17 |
69 | Fipamezole | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
70 | Fipamezole hydrochloride | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
71 | Fipamezole hydrochloride 30 mg oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
72 | Fipamezole hydrochloride 60 mg oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
73 | Fipamezole hydrochloride 90 mg oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
74 | Fludrocortisone | 1件: Fludrocortisone Fludrocortisone | 2件: D00986
D00986
,
D07967
| 1件: NR3C2 NR3C2 💬 | 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 3件: 6 6, 17, 81 |
75 | Flumazenil | 1件: Flumazenil Flumazenil | 1件: D00697
D00697
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 5件: 6 6, 13, 17, 18, 206 |
76 | FLUOXETINE | 1件: Fluoxetine Fluoxetine | 2件: D00326
D00326
,
D00823
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 4件: 13 13, 17, 78, 86 |
77 | Fluoxétine | 1件: Fluoxetine Fluoxetine | 2件: D00326
D00326
,
D00823
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 17 17 |
78 | Flutemetamol | 1件: Flutemetamol (18F) Flutemetamol (18F) | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
79 | Flutemetamol F18 | 2件: Flutemetamol Flutemetamol, Flutemetamol (18F) | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
80 | Gold | 1件: Gold Gold | - | - | - | 43件: 2 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 171, 193, 218, 222, 224, 227, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318 |
81 | Green Tea | 1件: Green tea leaf Green tea leaf | 1件: D06903
D06903
| - | - | 5件: 6 6, 17, 28, 46, 96 |
82 | GREEN TEA LEAF | 2件: Green tea leaf Green tea leaf, Tea leaf | 1件: D06903
D06903
| - | - | 1件: 17 17 |
83 | Homeostasis Model Assessment of insulin resistance (HOMA) | - | - | - | - | 1件: 17 17 |
84 | Hydrogen | 1件: Hydrogen Hydrogen | - | - | - | 7件: 5 5, 6, 13, 17, 83, 97, 226 |
85 | Inosine | 1件: Inosine Inosine | 1件: D00054
D00054
| - | - | 5件: 2 2, 6, 13, 17, 122 |
86 | Intranasal Insulin | - | - | - | - | 2件: 6 6, 17 |
87 | Intravenous immunoglobulin (IVIg) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 4件: 14 14, 17, 164, 296 |
88 | Intravesical injection of Botulinum A toxin | - | - | - | - | 2件: 6 6, 17 |
89 | IUPAC name: 1-(2-Isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d] pyrimidin-4-one | - | - | - | - | 1件: 17 17 |
90 | IVIG | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 8件: 11 11, 13, 14, 17, 35, 50, 51, 65 |
91 | JP-1730/F01 | - | - | - | - | 2件: 6 6, 17 |
92 | JP-1730/F02 | - | - | - | - | 2件: 6 6, 17 |
93 | JP-1730/F03 | - | - | - | - | 2件: 6 6, 17 |
94 | L-Threo DOPS | 1件: Droxidopa Droxidopa | 1件: D01277
D01277
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 17 17 |
95 | Levodopa | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 8件: 2 2, 4, 6, 17, 90, 140, 164, 201 |
96 | Levodopa test | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 17 17 |
97 | LITHIUM CARBONATE | 2件: Carbonate ion Carbonate ion, Lithium carbonate | 1件: D00801
D00801
| - | - | 6件: 2 2, 13, 17, 18, 19, 127 |
98 | LITIO CARBONATO | - | - | - | - | 2件: 2 2, 17 |
99 | Losartan | 1件: Losartan Losartan | 2件: D00357
D00357
,
D08146
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 18件: 17 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
100 | Lu AF82422 | - | - | - | - | 2件: 6 6, 17 |
101 | Metoprolol | 1件: Metoprolol Metoprolol | 3件: D00601
D00601
,
D02358
,
D05011
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 6件: 17 17, 57, 58, 113, 193, 226 |
102 | Metoprolol tartrate 50 mg | 1件: Metoprolol Metoprolol | 3件: D00601
D00601
,
D02358
,
D05011
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 17 17 |
103 | Midodrine | 1件: Midodrine Midodrine | 2件: D01307
D01307
,
D08220
| 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 3件: 6 6, 17, 58 |
104 | Midodrine or atomoxetine pill | 2件: Atomoxetine Atomoxetine, Midodrine | 4件: D01307
D01307
,
D02574
,
D07473
,
D08220
| 4件: ADRA1A ADRA1A, ADRA1B, ADRA1D, SLC6A2 💬 | 8件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Synaptic vesicle cycle, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 17 17 |
105 | Modal | - | - | - | - | 5件: 2 2, 6, 17, 46, 70 |
106 | N1,N3-BIS(2-MERCAPTOETHYL) ISOPHTHALAMIDE | - | - | - | - | 2件: 5 5, 17 |
107 | NBMI | - | - | - | - | 2件: 5 5, 17 |
108 | Nebivolol | 1件: Nebivolol Nebivolol | 1件: D05127
D05127
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 17 17, 85, 113, 167 |
109 | Nebivolol 5 mg | 1件: Nebivolol Nebivolol | 1件: D05127
D05127
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 17 17 |
110 | Nitrogen | 1件: Nitrogen Nitrogen | 1件: D00083
D00083
| - | - | 6件: 5 5, 6, 17, 171, 211, 299 |
111 | Normal Saline | - | - | - | - | 18件: 6 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 271, 276, 296, 299 |
112 | NT 101 | - | - | - | - | 4件: 5 5, 6, 7, 17 |
113 | Other: Abdominal compression | - | - | - | - | 1件: 17 17 |
114 | Other: Brain MRI (magnetic resonance imaging) | - | - | - | - | 1件: 17 17 |
115 | Other: Sham abdominal compression | - | - | - | - | 1件: 17 17 |
116 | PROZAC | - | - | - | - | 1件: 17 17 |
117 | Pseudoephedrine | 1件: Pseudoephedrine Pseudoephedrine | 4件: D00485
D00485
,
D05648
,
D05649
,
D08449
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 17 17 |
118 | Pseudoephedrine + 480 ml water | 2件: Pseudoephedrine Pseudoephedrine, Water | 5件: D00001
D00001
,
D00485
,
D05648
,
D05649
,
D08449
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 17 17 |
119 | Pseudoephedrine + 50 ml water | 2件: Pseudoephedrine Pseudoephedrine, Water | 5件: D00001
D00001
,
D00485
,
D05648
,
D05649
,
D08449
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 17 17 |
120 | Raclopride | 1件: Raclopride Raclopride | - | - | - | 4件: 5 5, 6, 7, 17 |
121 | Radiation: H215O PET | - | - | - | - | 2件: 6 6, 17 |
122 | Radiation: PET (Positron Emission Tomography) Study | - | - | - | - | 1件: 17 17 |
123 | Rasagilina | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
124 | RASAGILINA MESILATO | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
125 | Rasagiline | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 4件: 2 2, 5, 6, 17 |
126 | RASAGILINE MESYLATE | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
127 | Rifampicin | 1件: Rifampicin Rifampicin | 1件: D00211
D00211
| - | - | 6件: 6 6, 17, 46, 93, 299, 338 |
128 | RILUZOLE | 1件: Riluzole Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
129 | Rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 49件: 6 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
130 | SAFINAMIDE | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
131 | SAFINAMIDE METANSOLFONATO | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
132 | SAFINAMIDE METHANESULFONATE | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
133 | Saline | - | - | - | - | 10件: 6 6, 13, 17, 53, 67, 78, 86, 97, 168, 299 |
134 | Sham binder | - | - | - | - | 1件: 17 17 |
135 | Sham compression | - | - | - | - | 2件: 6 6, 17 |
136 | Sildenafil25 mg | - | - | - | - | 1件: 17 17 |
137 | Sirolimus | 1件: Sirolimus Sirolimus | 1件: D00753
D00753
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 36件: 6 6, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 |
138 | Sirolimus 2 MG | 1件: Sirolimus Sirolimus | 1件: D00753
D00753
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 17 17 |
139 | Sunphenon EGCG | 1件: Epigallocatechin gallate Epigallocatechin gallate | - | - | - | 3件: 13 13, 17, 113 |
140 | TD-9855 | - | - | - | - | 2件: 6 6, 17 |
141 | Tea leaf | 1件: Tea leaf Tea leaf | - | - | - | 1件: 17 17 |
142 | Tllsh2910 | - | - | - | - | 1件: 17 17 |
143 | Tolterodine | 1件: Tolterodine Tolterodine | 2件: D00646
D00646
,
D01148
| 1件: CHRM3 CHRM3 💬 | 11件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 2件: 17 17, 53 |
144 | Trimethaphan | 1件: Trimethaphan Trimethaphan | 1件: D00612
D00612
| 1件: CHRNA10 CHRNA10 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 17 17 |
145 | Ubiquinol | 1件: Ubiquinol Ubiquinol | - | - | - | 3件: 6 6, 8, 17 |
146 | Verdiperstat | 1件: Verdiperstat Verdiperstat | 1件: D11684
D11684
| 1件: MPO MPO 💬 | 5件: Acute myeloid leukemia Acute myeloid leukemia, Drug metabolism - other enzymes, Neutrophil extracellular trap formation, Phagosome, Transcriptional misregulation in cancer 💬 | 3件: 2 2, 17, 127 |
147 | Water | 1件: Water Water | 1件: D00001
D00001
| - | - | 23件: 2 2, 5, 6, 13, 17, 19, 22, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 |
148 | Xadago | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
149 | Xeomin | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 7件: 5 5, 6, 7, 13, 15, 17, 113 |
150 | Z7219 | - | - | - | - | 1件: 17 17 |
151 | Zoledronic acid | 1件: Zoledronic acid Zoledronic acid | 4件: D01968
D01968
,
D06378
,
D06379
,
D08689
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 12件: 5 5, 6, 13, 17, 46, 93, 95, 96, 270, 274, 299, 333 |
152 | Zoledronic Acid 5Mg/Bag 100Ml Inj | 1件: Zoledronic acid Zoledronic acid | 4件: D01968
D01968
,
D06378
,
D06379
,
D08689
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 3件: 5 5, 6, 17 |